Published in J Immunol on September 01, 1983
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00
T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med (1988) 2.14
Human interleukin 1. Purification to homogeneity. J Exp Med (1985) 1.72
Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc Natl Acad Sci U S A (1986) 1.70
Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci U S A (1987) 1.65
Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J Exp Med (1986) 1.40
Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol (1992) 1.32
Regulation of interleukin 1 and its receptor in human keratinocytes. Proc Natl Acad Sci U S A (1989) 1.26
Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta. Proc Natl Acad Sci U S A (1987) 1.20
Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J Exp Med (1992) 1.17
Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery. Clin Exp Immunol (1991) 0.98
In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation. Clin Diagn Lab Immunol (1994) 0.92
Ligand-induced desensitization of interleukin 1 receptor-initiated intracellular signaling events in T helper lymphocytes. J Exp Med (1994) 0.87
Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation. Clin Exp Immunol (1995) 0.79
Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol (1996) 0.78
Modulation of IL-1 production and IL-1 release during experimental trypanosome infections. Immunology (1989) 0.78
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00
Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science (1986) 2.84
The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem (1987) 2.78
Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem (1988) 2.46
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol (1989) 2.11
Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med (1997) 2.10
In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol (1983) 1.97
Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. J Exp Med (1987) 1.85
Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 1.80
Human interleukin 1. Purification to homogeneity. J Exp Med (1985) 1.72
Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J Biol Chem (1986) 1.71
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest (2001) 1.70
Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci U S A (1987) 1.65
Control of experimental contact sensitivity. Adv Immunol (1980) 1.54
The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol (2000) 1.53
Molecular characterization of interleukin 2. Immunol Rev (1982) 1.52
Lymphokine purification by reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 1.51
A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol (2006) 1.49
Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J Biol Chem (1994) 1.41
Localization of human mononuclear cell interleukin 1. J Immunol (1987) 1.33
Characterization of gamma-aminobutyric acid receptor GABAB(1e), a GABAB(1) splice variant encoding a truncated receptor. J Biol Chem (2000) 1.18
Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action. J Immunol (1982) 1.18
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics (1999) 1.17
Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis (1997) 1.17
Anatomy of mitochondrial DNA from Paramecium aurelia. Mol Gen Genet (1980) 1.11
Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope. Scand J Immunol (2006) 1.09
Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J Neuroimmunol (1997) 1.09
Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol (1999) 1.05
Purification to homogeneity of a human hematopoietic growth factor that stimulates the growth of a murine interleukin 3-dependent cell line. J Immunol (1986) 1.02
Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J (1998) 1.01
A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. J Hosp Infect (2011) 1.00
Efficient induction of immediate tolerance to contact sensitivity by hapten-modified spleen cells requires Ia+ cells compatible with recipient. Nature (1979) 0.99
Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int (1998) 0.99
MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function. Ren Fail (2008) 0.99
A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant (2001) 0.98
IL 1 expression in a clone of human T cells. J Immunol (1987) 0.97
Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells. J Immunol (1987) 0.97
Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis (1996) 0.96
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int (2001) 0.96
IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. J Immunol (1989) 0.94
Production of IL-1 alpha and IL-1 beta by clones of EBV transformed, human B cells. Mol Immunol (1987) 0.94
The impact of skin disease following renal transplantation on quality of life. Br J Dermatol (2005) 0.93
Limiting dilution analysis of interleukin 2 and colony-stimulating factor producer cells in normal and autoimmune mice. J Immunol (1984) 0.92
The treatment of induced immune deficiency with interleukin-2. Immunol Lett (1985) 0.91
Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. Am J Kidney Dis (1999) 0.91
Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS. Infect Immun (1995) 0.91
Manifestations of Von Hippel Lindau syndrome: a retrospective national review. QJM (2013) 0.90
Generation of anti-peptide monoclonal antibodies which recognize mature CSF-2 alpha (IL 3) protein. J Immunol (1985) 0.89
Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology (2000) 0.88
A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol (1996) 0.88
In vivo treatment with IL-1 reduces the severity and duration of antigen-induced arthritis in rats. J Immunol (1988) 0.88
Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience. Ren Fail (1996) 0.87
SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity. J Leukoc Biol (2001) 0.87
Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection. Clin Transplant (2009) 0.87
Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis. Pediatr Transplant (2006) 0.87
Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides. Circ Shock (1992) 0.87
Adequacy of haemodialysis with cuffed central-vein catheters. Nephrol Dial Transplant (1998) 0.86
Granulocyte/macrophage colony stimulating factor. A potent activation signal for mature macrophages and monocytes. Int Arch Allergy Appl Immunol (1989) 0.86
Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand. Clin Immunol (2002) 0.86
Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides. Circ Shock (1992) 0.86
Pleuroperitoneal leak complicating peritoneal dialysis: a case series. Int J Nephrol (2011) 0.86
Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glomerulosclerosis. Kidney Int (1999) 0.85
Access recirculation in temporary hemodialysis catheters as measured by the saline dilution technique. Am J Kidney Dis (2000) 0.85
Nature of hapten-modified determinants involved in induction of T cell tolerance and suppressor T cells to NDFB contact sensitivity. J Immunol (1980) 0.84
The role of immunosuppression in the pathogenesis of basal cell carcinoma. Br J Dermatol (2006) 0.83
NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients. Ann Neurol (2000) 0.82
Human thymocytes express CCR-3 and are activated by eotaxin. Blood (1999) 0.82
Warfarin use in hemodialysis patients: what is the risk? Clin Nephrol (2011) 0.81
Lymphopoiesis and IL-7. Int J Cell Cloning (1990) 0.81
Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23. Infect Immun (1995) 0.81
Cytokine-dependent thymocyte responses. II. Generation of cytotoxic T lymphocytes from immature thymocytes. J Immunol (1982) 0.80
Dialysis catheter 'fibrin-sheath stripping': a cautionary tale! Nephrol Dial Transplant (1997) 0.79
Immunosuppressive phenotype of corticotropin-releasing factor transgenic mice is reversed by adrenalectomy. Cell Immunol (1997) 0.79
Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration. QJM (1996) 0.79
An unusual case of cancer of the urachal remnant following repair of bladder exstrophy. Ir J Med Sci (2009) 0.79
Crescentic IgA nephropathy and acute renal failure in an HIV-positive patient with enteric salmonella infection. Nephrol Dial Transplant (1996) 0.78
Renal transplantation, immunosuppression and the skin: an update. Photodermatol Photoimmunol Photomed (2005) 0.78
Twenty-year survivors of kidney transplantation. Am J Transplant (2012) 0.78
Pandemic H1N1 (2009) and renal failure: the experience of the Irish national tertiary referral centre. Ir J Med Sci (2010) 0.77
Evaluation of experimentally induced Fusobacterium necrophorum infections in mice. Infect Immun (1977) 0.77
Complications and characteristics of patients referred to a joint diabetes renal clinic in Ireland. Ir J Med Sci (2012) 0.77
An assessment of the long-term health outcome of renal transplant recipients in Ireland. Ir J Med Sci (2009) 0.77
ACE inhibitors do not affect erythropoietin efficacy in haemodialysis patients. Nephrol Dial Transplant (1994) 0.77
Losartan in post-transplant erythrocytosis. Nephrol Dial Transplant (1996) 0.77
Haemodialysis catheter bacteraemia: evolving strategies. Curr Opin Nephrol Hypertens (1998) 0.76
Nephrogenic systemic fibrosis. Ir Med J (2010) 0.76
Fulminant hepatitis and multisystem organ failure following yellow fever vaccination: description of a fatal case. Anaesth Intensive Care (2014) 0.76
Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation. Transplant Proc (2009) 0.76
Improved renal allograft survival with vitamin D receptor polymorphism. Ren Fail (2007) 0.76
The frequency and significance of thiopurine S-methyltransferase gene polymorphisms in azathioprine-treated renal transplant recipients. Br J Dermatol (2006) 0.75
The induction of tolerance to DNFB contact sensitivity using hapten modified lymphoid cells. I. Cellular requirements for rapid induction of tolerance. Cell Immunol (1980) 0.75
Identification of interleukin-2 producer and responder T lymphocyte subpopulations by immunoperoxidase staining. Prog Clin Biol Res (1985) 0.75
Home haemodialysis in Ireland. Ir J Med Sci (2012) 0.75
Multi organ transplantation: a review of the Irish experience. Ir Med J (2005) 0.75
Do AshSplit haemodialysis catheters provide better flow rates in the long term? Ren Fail (2007) 0.75
Lymphokines: from conjecture to the clinic. Semin Oncol (1986) 0.75